The plasticity and heterogeneity of cancer cells promote the acquisition of endothelial cell markers such as vascular endothelial growth factor receptor 2 (VEGFR2), CD31 and VE-Cadherin (CD144). The gene discussed is CDH5; the disease is cancer.